Which Canadian medicines the world is asking for
Every cell below counts distinct organisations that asked Nexara Health to quote a molecule in that region and quarter, together with the number of quoted request lines. Cells with fewer than three distinct requesters are suppressed, so no single buyer can be inferred. No customer name, contact, price or volume is published — this is demand direction, not commercial data.
The signal is useful because it is upstream of dispensing data: a buyer asks for a quote weeks before a purchase order exists and months before the volume appears in national statistics. Rising requester counts for a molecule in one region usually mean a local supply problem, a tender being prepared, or a trial recruiting there.
2026 Q3
Canada
| Molecule | Requesters | Request lines |
|---|
| semaglutide | 3 | 12 |
EU / EEA
| Molecule | Requesters | Request lines |
|---|
| cyclosporine | 5 | 11 |
| theophylline | 3 | 3 |
UK & Ireland
| Molecule | Requesters | Request lines |
|---|
| thyroid | 3 | 8 |
United States
| Molecule | Requesters | Request lines |
|---|
| semaglutide | 5 | 21 |
2026 Q2
Asia-Pacific
| Molecule | Requesters | Request lines |
|---|
| linaclotide | 3 | 6 |
EU / EEA
| Molecule | Requesters | Request lines |
|---|
| thyroid | 5 | 20 |
| belzutifan | 4 | 4 |
| belumosudil (belumosudil mesylate) | 3 | 3 |
| phenelzine (phenelzine sulfate) | 3 | 3 |
| cyclosporine | 3 | 3 |
Other
| Molecule | Requesters | Request lines |
|---|
| semaglutide | 3 | 19 |
| mexiletine hydrochloride | 3 | 6 |
UK & Ireland
| Molecule | Requesters | Request lines |
|---|
| thyroid | 3 | 9 |
| triamcinolone acetonide | 3 | 5 |
United States
| Molecule | Requesters | Request lines |
|---|
| tirzepatide | 7 | 78 |
| semaglutide | 10 | 46 |
| apixaban | 3 | 5 |
| olaparib | 3 | 5 |
| fluticasone propionate | 3 | 3 |
2026 Q1
EU / EEA
| Molecule | Requesters | Request lines |
|---|
| thyroid | 4 | 11 |
| tarlatamab | 3 | 10 |
United States
| Molecule | Requesters | Request lines |
|---|
| semaglutide | 6 | 34 |
| tirzepatide | 5 | 20 |
| tafamidis | 3 | 3 |
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for the molecules listed above and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1-431-588-9055.